Oral Thrush Treatment Market

Oral Thrush Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Oral thrush is a fungal infection caused by accumulation of species Candidas on the mucus membrane of the mouth
Candida albicans infects men and women of all age groups. It is the normal inhabitant of oral microbiota in about 50% of the global population. Candida albicans is normally present in the mouth, but sometimes it can overgrow and become pathogenic to the host tissue.
Oral thrush usually causes the development of a creamy white lesion on the tongue or inner cheeks. In some cases, it could spread to the gums, tonsils, and/or roof of the oral cavity. In severe cases such as cancer or HIV/AIDS, lesions get worse and spread downward into the esophagus.
Diagnosis of oral thrush depends on the location. If the thrush is limited to the mouth, then it can be diagnosed by microscopic examination and blood tests. If oral thrush has spread into the esophagus, then it can be diagnosed with the help of biopsy, endoscopic examination, and/or physical examination.
Moreover, oral thrush can be treated with topical anti-infectives such as gentian violet and antifungals such as fluconazole and clotrimazole

Increase in incidence of candidiasis infections and rise in awareness about fungal infections are projected to drive the global oral thrush treatment market during the forecast period
According to the Centers for Disease Control and Prevention (CDC), during 2013–2017, the average incidence of candidemia was 9 per 100,000 people in the U.S. However, this number varies substantially by geographic location and patient population. An estimated 25,000 cases of candidemia are recorded in the country each year.
Rise in hygiene awareness in developing countries and popularity of over-the-counter antifungal drugs are anticipated to propel the global oral thrush treatment market in the near future
However, availability of alternative treatments such digestive health probiotics and occurrence of severe adverse drug reactions are expected to restrain the global oral thrush treatment market

In terms of region, the global oral thrush treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America is likely to account for major share of the global market due to rise in usage of these medications and high health care expenditure. Additionally, rapid uptake of new products, concentration of major players in the U.S., and larger use oral hygiene products are projected to augment the market in the region.
Europe is anticipated to be a significant market for oral thrush treatment during the forecast period, due to rise in prevalence of fungal infections and increase in awareness about new treatment options
The oral thrush treatment market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Growth of the market in the region can be attributed to rise in awareness about personal hygiene and access to better health care facilities.
The market in Latin America and Middle East & Africa is likely to grow at a steady pace due to the presence of rapidly developing economies and lifestyle changes of the population in these regions

Key players operating in the global oral thrush treatment market are:

Global Oral Thrush Treatment Market, by Drug

Global Oral Thrush Treatment Market, by Route of Administration

Global Oral Thrush Treatment Market, by Distribution Channel

Global Oral Thrush Treatment Market, by Region

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa